MEND: Summary for Micrus Endovascular Corporation - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:28am EST - Canadian Markets open in 9 hours and 2 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Micrus Endovascular Corp. (MEND)

On Feb 9: 18.60 USD

0.73 (4.09%)

MORE ON MEND

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Micrus Endovascular Corporation (NGM:MEND) Delayed quote data

After Hours: 18.60 0.00 (0.00%) as of 4:34pm EST on 02/09/10

Last Trade:	18.60 USD
Trade Time:	Feb 9
Change:	0.73 (4.09%)
Prev Close:	17.87
Open:	17.99
Bid:	17.49 x 100
Ask:	19.67 x 200
1y Target Est:	21.45

Day's Range:	17.89 - 18.78
52wk Range:	4.13 - 18.78
Volume:	252,682
Avg Vol (3m):	93,071.4
Market Cap:	297.71M
P/E (ttm):	30.95
EPS (ttm):	0.60
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add MEND to Portfolio

Download Data

HEADLINES

•	Micrus Endovascular (MEND): Zacks Rank Buy
	Zacks.com (Mon, Feb 8)

•	New Star Analyst Rankings for Micrus Endovascular Corporation
	StarMine (Sat, Feb 6)

•	MICRUS ENDOVASCULAR CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Feb 5)

•	Micrus Endovascular reports fiscal 3rd-qtr profit
	AP (Thu, Feb 4)

•	Micrus moves from Q3 loss to $3.3M profit
	at bizjournals.com (Thu, Feb 4)

•	MICRUS ENDOVASCULAR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
	EDGAR Online (Thu, Feb 4)

•	Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20
	Business Wire (Thu, Feb 4)

•	Micrus Endovascular to Hold Fiscal 2010 Third Quarter Conference Call on February 4
	Business Wire (Thu, Jan 28)

•	Cashing In on Obamacare
	at Motley Fool (Thu, Jan 21)

•	Helen of Troy Ltd. (HELE): Zacks Rank Buy
	Zacks.com (Mon, Jan 18)

•	Zacks Releases Four Powerful ''Buy'' Stocks: Encore Capital Group, Inc., Harris Corp., Micrus Endovascular Corp. and Whirlpool Corporation
	Zacks.com (Thu, Jan 14)

•	Micrus Endovascular Corp. (MEND): Zacks Rank Buy
	Zacks.com (Thu, Jan 14)

•	Coverage initiated on Micrus Endovascular by Rodman & Renshaw
	Briefing.com (Fri, Jan 8)

•	Micrus Endovascular to Present at January Investment Conferences
	Business Wire (Tue, Jan 5)

More Headlines for MEND...

ANALYST

EPS Est (next year) (Mar-10) :	0.71
EPS Est (in 2 years) (Mar-11) :	0.76
Avg Rec (current)*:	1.6
PEG Ratio:	0.78

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Micrus Endovascular Corporation develops, manufactures, and markets implantable and disposable medical devices to treat cerebral vascular diseases. It offers MicruSphere Microcoil, a framing coil that stabilizes the aneurysm; Presidio Microcoil, a...

Full Company Profile

Add to Portfolio

Email to a Friend

•